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a b s t r a c t
Skeletal myogenesis in the embryo is regulated by the coordinated expression of the MyoD family of
muscle regulatory factors (MRFs). MyoD and Myf-5, which are the primary muscle lineage-determining
factors, function in a partially redundant manner to establish muscle progenitor cell identity. Previous
diphtheria toxin (DTA)-mediated ablation studies showed that MyoDþ progenitors rescue myogenesis in
embryos in which Myf-5-expressing cells were targeted for ablation, raising the possibility that the
regulative behavior of distinct, MRF-expressing populations explains the functional compensatory
activities of these MRFs. Using MyoDiCre mice, we show that DTA-mediated ablation of MyoD-
expressing cells results in the cessation of myogenesis by embryonic day 12.5 (E12.5), as assayed by
myosin heavy chain (MyHC) and Myogenin staining. Importantly, MyoDiCre/þ;R26DTA/þ embryos exhib-
ited a concomitant loss of Myf-5þ progenitors, indicating that the vast majority of Myf-5þ progenitors
express MyoD, a conclusion consistent with immunoﬂuorescence analysis of Myf-5 protein expression in
MyoDiCre lineage-labeled embryos. Surprisingly, staining for the paired box transcription factor, Pax7,
which functions genetically upstream of MyoD in the trunk and is a marker for fetal myoblasts and
satellite cell progenitors, was also lost by E12.5. Speciﬁc ablation of differentiating skeletal muscle in
ACTA1Cre;R26DTA/þ embryos resulted in comparatively minor effects on MyoDþ , Myf-5þ and Pax7þ
progenitors, indicating that cell non-autonomous effects are unlikely to explain the rapid loss of
myogenic progenitors in MyoDiCre/þ;R26DTA/þ embryos. We conclude that the vast majority of myogenic
cells transit through a MyoDþ state, and that MyoDþ progenitors are essential for myogenesis and stem
cell development.
& 2013 Elsevier Inc. All rights reserved.
Introduction
The MyoD family of basic helix-loop-helix muscle transcription
factors (MyoD, Myf-5, Myogenin, Mrf4) serves central functions in
the regulatory circuitry that controls skeletal muscle determina-
tion and differentiation. MyoD and Myf-5 play fundamental roles
in muscle lineage determination, and mice lacking both MRF
undergo only limited embryonic myogenesis, which is directed
by Mrf4 (Kassar-Duchossoy et al., 2004, 2005). Ultimately,
embryos lacking both MyoD and Myf-5 are essentially devoid of
skeletal muscle and die perinatally (Rudnicki et al., 1993; Kaul
et al., 2000; Kassar-Duchossoy et al., 2004, 2005). Loss of either
Myf-5 or MyoD, however, result in only minor and transient
muscle deﬁciencies in epaxial and hypaxial myogenesis, respec-
tively (Braun et al., 1992; Rudnicki et al., 1992; Kablar et al., 1997;
Tajbakhsh et al., 1997), demonstrating that each MRF can func-
tionally compensate for the other's absence.
Whereas genetic interactions controlling early myogenesis
have been intensively investigated, important questions concern-
ing the nature of MyoD and Myf-5 genetic redundancy remain
unresolved. For example, it is unclear to what extent the compen-
satory activities of MyoD and Myf-5 reﬂect similar molecular
activities in myogenic progenitors that express both factors, or
arise from regulative behavior of distinct myogenic pools that
express either MyoD or Myf-5. Immunostaining and in situ hybri-
dization studies have revealed extensive co-expression, but also
considerable cellular heterogeneity, in Myf-5 and MyoD expres-
sion, with individual cells or myogenic regions often expressing
either MyoD or Myf-5 (Smith et al., 1994; Cossu et al., 1996;
Tajbakhsh et al., 1998; Relaix et al., 2005; Gensch et al., 2008;
Haldar et al., 2008). Initially, this heterogeneity reﬂects distinct
temporal and spatial patterns of activation of these muscle
regulatory genes in early myogenesis, principally in epaxial and
hypaxial somite domains (Sassoon et al., 1989; Ott et al., 1991;
Smith et al., 1994; Goldhamer et al., 1995; Cossu et al., 1996; Relaix
et al., 2005). However, even in the limb buds, where Myf-5 and
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MyoD activation is temporally coincident, and at later stages in
muscle forming regions that show temporally distinct patterns of
activation, myoblasts singly positive for either MyoD or Myf-5 are
prevalent (Gensch et al., 2008; Haldar et al., 2008). These data are
consistent with the intriguing possibility that developing muscle
beds include distinct muscle progenitor populations that could
provide the cellular substrates for the engagement of compensa-
tory mechanisms to drive myogenesis when one or more myo-
genic populations is lost, or when a progenitor population is
rendered incapable of myogenic activity due to the loss of either
MyoD or Myf-5. However, most studies of MRF expression hetero-
geneity have utilized immunohistological methods, which provide
a static view of MRF expression at discrete stages of development
and cannot be used to ascertain the extent to which myoblasts
singly positive for MyoD or Myf-5 represent distinct, independent
progenitor pools that express only one factor throughout their
developmental history. In addition, MyoD and Myf-5 expression
are cell cycle regulated (Kitzmann et al., 1998) and have short
(o1 h) protein and mRNA half-lives (Thayer et al., 1989; Carnac
et al., 1998), which likely contributes to the apparent degree of
non-overlap of MyoD and Myf-5 expression.
Cell-speciﬁc ablation using Cre-dependent DTA expression pro-
vides a powerful means of interrogating progenitor cell dynamics.
Results of previous DTA ablation studies suggested the existence of a
functionally signiﬁcant pool of MyoDþ progenitors that do not
express Myf-5 (Gensch et al., 2008; Haldar et al., 2008). Thus,
ablation of Myf-5-expressing cells had only transient effects on
myogenesis; myogenic activity—driven by MyoDþ progenitors—
was restored by approximately early fetal stages, generating muscle
that appeared normal by histological and ultrastructural criteria.
These data are consistent with the existence of at least two distinct
myogenic progenitor populations based on the presence or absence
of Myf-5 expression and demonstrate the marked regulative capacity
of developing skeletal muscle.
We sought to further clarify the interrelationship between
embryonic myogenic populations by immunoﬂuorescence ana-
lyses, lineage tracing, and targeted DTA-mediated ablation of
MyoD-expressing cells using MyoDiCre mice (Kanisicak et al.,
2009; Yamamoto et al., 2009). The MyoDiCre allele allows highly
efﬁcient labeling of embryonic and fetal myoblasts, as well as
satellite cell progenitors, and is not expressed outside of myogenic
populations in the embryo (Kanisicak et al., 2009; Yamamoto et al.,
2009). Consistent with previous ﬁndings, we observed consider-
able heterogeneity in MyoD and Myf-5 protein expression at each
developmental stage examined. Ablation of MyoD-expressing
cells, however, resulted in the loss of myoﬁbers and myogenic
progenitors (deﬁned by Pax7 or Myf-5 expression) by E12.5,
approximately 2 days after the onset of detectable MyoDiCre-
dependent reporter gene expression. Disruption of the muscle
environment by targeting DTA expression speciﬁcally to differen-
tiating muscle cells had a comparatively minor effect on myogenic
progenitors, indicating that cell non-autonomous effects cannot
explain the rapid loss of Pax7þ or Myf-5þ progenitors following
ablation of MyoD-expressing cells. These data show that the vast
majority of myogenic progenitors transit through a MyoDþ stage
and that myogenesis cannot be rescued by MyoD-non-expressing
embryonic progenitors.
Materials and methods
Mice and genotyping
Animal procedures were reviewed and approved by the Univer-
sity of Connecticut's Institutional Animal Care and Use Committee.
Production and characterization of MyoDiCre, R26NZG, and R26NG mice
was described previously (Kanisicak et al., 2009; Yamamoto et al.,
2009). ROSA26-eGFP-DTA (R26DTA; Ivanova et al., 2005; JAX
#006331), ROSA-DTA (R-DTA; Haldar et al., 2008; Wu et al., 2006;
JAX #009669) and ACTA1Cre (Miniou et al., 1999; JAX #006139) mice
were purchased from Jackson Laboratories. Experimental animals
were on an enriched FVB background. PCR-based genotyping of DNA
isolated from tail biopsies or yolk sacs was done as previously
described (Miniou et al., 1999; Ivanova et al., 2005; Kanisicak et al.,
2009; Yamamoto et al., 2009), except that sucrose was added to a
ﬁnal concentration of 12% for all PCR reactions.
Mouse crosses
To generate experimental embryos for DTA ablation and lineage
tracing, the MyoDiCre knockin allele and ACTA1Cre transgene were
introduced through the male germline to avoid the possibility of
premature Cre-mediated recombination due to leaky Cre expres-
sion and accumulation in the egg (see Chen et al., 2005 and
references therein). As an additional precaution, Cre drivers and
DTA or reporter alleles were introduced through different parents,
when possible. Typically, heterozygous parents were used for
crosses to generate all classes of littermate controls, although in
some cases, R26DTA/DTA females were used to increase the efﬁciency
of generating experimental embryos. Control embryos were either
wild-type, or carried one copy of the Cre driver or DTA allele. No
phenotypic differences among these genotypes were observed.
Embryos were collected between embryonic day 10.5 (E10.5) and
E16.5, with noon on the day of the vaginal plug considered E0.5.
Staging of somite-stage embryos was conﬁrmed by morphological
criteria (Kaufman, 1992). Except where noted, at least three
embryos of each genotype for each developmental stage were
examined and representative images are shown.
Histology and immunoﬂuorescence
Embryos derived from crosses that included the Cre-dependent
GFP reporter allele, R26NG, were immediately ﬁxed in 2% paraf-
ormaldehyde (PFA) in PBS (20 mM sodium phosphate, 0.10 M NaCl,
pH 7.4) for 2 h at 4 1C, immersed in 15% sucrose in PBS at 4 1C for
2 h, and 30% sucrose O/N before being immersed in OCT com-
pound (Sakura Finetek) and frozen in liquid nitrogen. Embryos
from all other crosses were immersed in OCT compound immedi-
ately after collection and frozen in liquid nitrogen. Embryos were
stored at 80 1C.
Frozen embryos were cryostat sectioned at 12–14 μm, collected
on Superfrost Plus slides (Fisher), brieﬂy dried with a hair dryer,
and stored at 80 1C. Antigen retrieval was used for detection of
all proteins except Myf-5. After thawing, sections derived from
ﬁxed embryos were directly processed for antigen retrieval
whereas sections from unﬁxed embryos were ﬁrst ﬁxed in 2%
PFA/PBS for 20 min at 4 1C. For antigen retrieval, slides were
washed three times for 5 min each in PBS, incubated for 6 min
in 20 1C methanol, and washed as above. Slides were then
placed in 10 mM sodium citrate buffer, pH 6.0, and incubated in
a 1200 W microwave at 10% power for 20 min, followed immedi-
ately with incubation at 4 1C for 20 min.
The following antibodies and working dilutions were used for
immunoﬂuorescence. MyoD: monoclonal antibody (mAb) 5.8A (1:50
dilution; catalog # 554130, BD Pharmingen); Myf-5: rabbit polyclonal
antiserum (1:200 dilution; catalog # sc-302, Santa Cruz Biotechnol-
ogy); Myogenin: mAb F5D (1:1 dilution of hybridoma supernatant;
Developmental Studies Hybridoma Bank); Pax7: mAb Pax7 (1:1
dilution of hybridoma supernatant; Developmental Studies Hybri-
doma Bank); Pax3: mAb Pax3 (1:1 dilution of hybridoma super-
natant; Developmental Studies Hybridoma Bank); MyHC: mAb MF20
(1:1 dilution of hybridoma supernatant; Developmental Studies
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Hybridoma Bank); GFP: chicken polyclonal antiserum (1:250 dilu-
tion; catalog # 13970, Abcam).
For detection of MyHC and Myogenin, sections were blocked in
M.O.M. blocking solution (Vector Laboratories) O/N at 4 1C, washed
two times in PBS for 10 min each, incubated for 30 min in M.O.M.
diluent at room temperature (RT), and incubated in primary anti-
body suspended in M.O.M. diluent for 2 h at RT. After three 5 min
washes in PBS, sections were incubated in a 1:250 dilution of M.O.
M. Biotinylated Anti-Mouse IgG Reagent (Vector Laboratories) in M.
O.M. diluent for 30 min at RT, washed three times for 5 min each in
PBS, and incubated for 30 min in 1:400 dilution of Alexa Fluor 555-
conjugated Streptavidin (Invitrogen) in M.O.M. diluent for 30 min.
After three 5 min washes in PBS, sections were counterstained with
DAPI (0.1 μg/ml) and slides coverslipped using Fluoro-Gel (Electron
Microscopy Sciences). Immunoﬂuorescence detection of MyoD
followed a similar procedure through the primary antibody incuba-
tion step. After three 5 min washes in PBS, sections were incubated
in a 1:250 dilution of goat anti-mouse Alexa Fluor 568 in PBSMBT
(1X PBS, 1.5% Non-fat dried milk, 1.5% BSA, 0.1% Triton X-100) for 1 h
at RT, washed as above, and the signal ampliﬁed by incubation for
1 h at RT in a 1:250 dilution of donkey anti-goat Alexa Fluor 568 in
PBSMBT. Slides were washed, stained with DAPI and coverslipped
as above. For Pax7 and Pax3 immunoﬂuorescence, sections were
incubated in M.O.M. blocking solution for 2 h at RT, incubated O/N
at 4 1C in primary antibody suspended in PBSMBT, washed three
times for 5 min each in PBS, and subsequently processed as for
MyoD above. For detection of Myf-5, sections were blocked in
PBSMBT O/N at 4 1C, incubated for 30 min at RT in primary antibody
diluted in PBSMBT, and processed as for MyoD, Pax7 and Pax3
except that goat anti-rabbit Alexa Fluor 568 was used for the
secondary antibody. For immunoﬂuorescence detection of GFP,
sections were blocked O/N at 4 1C in PBSMBT, washed three times
for 5 min each in PBS, incubated in primary antibody diluted in
PBSMBT for 1 h at RT, washed in PBS as above, incubated in goat
anti-chicken Alexa Fluor 488 diluted in PBSMBT for 1 h at RT, and
washed, stained with DAPI and coverslipped as above.
Simultaneous detection of MyoD/GFP and MyoD/Myf-5 followed
the MyoD protocol in terms of antigen retrieval, blocking buffer,
diluent buffer, incubation times and antibody concentrations. For
detection of MyoD and GFP, sections were incubated with both
primary antibodies simultaneously and washed in PBS as above.
MyoD was then detected by sequential incubation in the secondary
(goat anti-mouse Alexa Fluor 568) and tertiary (donkey anti-goat
Alexa Fluor 568) antibodies as above. After three 5 min PBS washes,
sections were incubated with goat anti-chicken Alexa Fluor 488 to
detect GFP (native GFP ﬂuorescence was destroyed by antigen
retrieval). Control experiments veriﬁed negligible interaction
between the bound tertiary antibody and the goat anti-chicken
secondary antibody. For detection of MyoD and Myf-5, sections were
incubated with both primary antibodies simultaneously, washed in
PBS, incubated with both secondary antibodies simultaneously
(chicken anti-mouse Alexa Fluor 488 to detect MyoD and goat anti-
rabbit Alexa Fluor 568 to detect Myf-5) and washed in PBS. Sections
were then sequentially incubated in the tertiary antibodies, donkey
anti-goat Alexa Fluor 568 and goat anti-chicken Alexa Fluor 488, with
three 5 min PBS washes between antibody incubations. Slides were
washed, stained with DAPI and coverslipped as above.
For simultaneous detection of MyoD, Myf-5 and GFP, native GFP
ﬂuorescence was photographed prior to antigen retrieval, cover-
slips were removed, and sections were processed for antigen
retrieval and MyoD and Myf-5 immunodetection as above.
Whole mount in situ hybridization and X-gal staining
Whole mount in situ hybridization with digoxigenin-labeled
probes was performed as previously described (Henrique et al.,
1995; Yamamoto et al., 2007), with minor modiﬁcations related to
color development and storage. Brieﬂy, for color development,
embryos were incubated in BM Purple (Roche Applied Science)
overnight at room temperature. After color development, embryos
were washed three times in MABT for 3 h, and stored overnight
in MABT at room temperature. Embryos were subsequently
transferred to 70% ethanol for 30 min at room temperature, rinsed
in MABT and stored at 4 1C in MABT. The MyoD probe has
been previously described (Yamamoto et al., 2007). The Myf-5
probe represents a 613 nucleotide fragment of the Myf-5 cDNA
that was ampliﬁed by PCR using the following primers: Forward:
5′-CATATGGACATGACGGACGGC-3′, Reverse: 5′-AGCTGGACACGGA
GCTTTTA-3′.
Whole mount X-gal staining for detection of β-galactosidase
(β-gal) activity was done as previously described (Yamamoto et al.,
2007).
Microscopy and image collection
Imaging of whole mount embryos was performed on a Leica
MZFLIII ﬂuorescence stereomicroscope equipped with a Spot RT3
camera and Spot Advanced image capture software (Diagnostic
Instruments). Slides were imaged using either a Nikon E600
upright microscope equipped with a Spot RT3 camera or a Nikon
A1R four-laser spectral confocal microscope equipped with both a
multiline Argon laser (525/50 nm excitation) for Alexa Fluor 488
and a Coherent Sapphire 561 laser (600/50 nm excitation) for
Alexa Fluor 568. Separate channels were captured independently
and acquired with Nikon NIS-Elements software. All images were
processed and assembled in Photoshop with only minor adjust-
ments made to image brightness and contrast, when necessary.
Exposure times and post-capture manipulations were identical for
comparison groups (e.g. sections from control and DTA embryos at
a particular stage). Images that are composites of multiple micro-
graphs are noted in the ﬁgure legends.
Results
Cellular heterogeneity in MyoD and Myf-5 protein expression
We ﬁrst assessed the degree of overlap of MyoD-expressing and
Myf-5-expressing cells by immunoﬂuorescence to serve as a base-
line for DTA ablation and lineage tracing analyses. We focused on
E11.5 and E12.5 embryos, since in Myf-5 lineage-ablated embryos,
these stages encompassed the major period of recovery of myogenic
activity after an initial loss of MyoDþ progenitors, as revealed by
RT-PCR and in situ hybridization analysis for MyoD mRNA (Gensch
et al., 2008). Consistent with previous data (Smith et al., 1994; Cossu
et al., 1996; Tajbakhsh et al., 1998; Relaix et al., 2005; Gensch et al.,
2008; Haldar et al., 2008), we observed substantial cellular hetero-
geneity in Myf-5 and MyoD expression (Fig. 1). In the myotomes at
E11.5, for example, cells positive either for MyoD or Myf-5, as well
as double positive progenitors, were readily detected, with single
positive progenitors representing the majority of myogenic cells
(Fig. 1A, C–E). All three combinations of MRF expression were
observed throughout the dorsomedial to ventrolateral extent of
the myotomes, although MyoD-expressing cells tended to be less
abundant in central myotomes of interlimb somites (data not
shown), consistent with the distribution of MyoD mRNA and
MyoD-dependent reporter gene activity at this stage (Goldhamer
et al., 1992; Faerman et al., 1995; Goldhamer et al., 1995; Chen et al.,
2002). All three classes of MRF-expressing progenitors were also
present in the premuscle masses of E11.5 forelimb buds, with
myoblasts singly positive for Myf-5 being the most prevalent class
at this stage (Fig. 1A, H–J; data not shown). A high degree of cellular
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heterogeneity in MRF expression was also observed at E12.5
(Fig. 1M–O, R–T). Cell counts of MRFþ cells in the ventro-
proximal forelimb revealed that myogenic progenitors singly posi-
tive for either MyoD (54%) or Myf-5 (31%) were more abundant
than cells expressing both MRFs (15%) (n¼1878 cells, 5 embryos).
Similar results were obtained among progenitors derived from the
epaxial myotome (MyoDþMyf-5–, 53%; MyoDMyf-5þ , 29%;
MyoDþMyf-5þ , 18%) (n¼2922 cells, 5 embryos). Although this
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Fig. 1. Cellular heterogeneity in MyoD and Myf-5 protein expression. (A, B) Transverse cryostat section of an E11.5 MyoDiCre/þ;R26NG/þ embryo stained by
immunoﬂuorescence for MyoD and Myf-5 expression. Panel A is a merged double immunoﬂuorescence image; the GFP signal from the Cre-dependent GFP reporter,
R26NG, was destroyed during antigen retrieval prior to immunoﬂuorescence processing. Panel B was imaged for GFP expression (reﬂecting activity of theMyoDiCre allele) prior
to antigen retrieval and subsequently merge with the immunoﬂuorescence image. (C–G) The boxed myotomal region in A and B is shown at higher magniﬁcation as single
channel and merged images to show heterogeneity in MyoD and Myf-5 expression. (H–L) The boxed forelimb bud region in A and B is shown at higher magniﬁcation as
single channel and merged images. (M–V) Single channel and merged immunoﬂuorescence images from a forelimb-level myotome or premuscle mass of the proximal
forelimb bud of an E12.5 MyoDiCre/þ;R26NG/þ embryo. Sections were imaged for MyoD and Myf-5 protein expression with or without the GFP lineage marker, as above.
Panels A and B are assembled composites of multiple images. Examples of cells positive for both MyoD and Myf-5 (arrows), and singly positive for either MyoD (white
arrowheads) or Myf-5 (blue arrowheads) are shown. LB, limb bud. Scale bars represent 200μm in A and B, and 50 μm in C–V.
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enumeration of MRFþ cells should be considered an approximation
because of inherent difﬁculty in identifying progenitors expressing
low levels of MyoD or Myf-5, these data reveal substantial hetero-
geneity among myoblasts populating the developing muscle beds at
these developmental stages.
To further address the interrelationships and stability of the
myogenic populations described above, we analyzed Myf-5
expression in embryos in which MyoD-expressing cells were
stably lineage marked using Cre/loxP recombination methods.
For this experiment, we used MyoDiCre knockin mice, in which
Cre is faithfully and efﬁciently expressed under endogenous MyoD
control (Kanisicak et al., 2009; Yamamoto et al., 2009), and a
highly sensitive Cre-dependent eGFP reporter, R26NG (Yamamoto
et al., 2009). First, the dynamics of MyoD protein expression
was addressed by comparing MyoD and GFP expression in Myo-
DiCre/þ;R26NG/þ embryos. The myotomes and muscle beds of the
forelimb buds at E11.5 were highly heterogeneous in terms of
MyoD and GFP expression (Fig. S1A–F). This was particularly
evident in the forelimb buds, where MyoDþ cells that were
negative for the lineage marker (i.e., GFP–) predominated (Fig.
S1D–F). By E12.5, however, the number of MyoDþGFP– cells was
substantially reduced (Fig. S1G–L), suggesting that the
MyoDþGFP– cells at E11.5 represented progenitors that had
recently activated MyoD expression but had insufﬁcient time to
accumulate detectable levels of GFP. Based on published whole
mount in situ hybridization analyses (Tajbakhsh et al., 1997; Chen
et al., 2002; Chen and Goldhamer, 2004; Kanisicak et al., 2009),
the lag between the initiation of MyoD expression and accumula-
tion of detectable MyoDiCre-dependent reporter gene expression
(Figs. 1 and 2; Kanisicak et al., 2009, unpublished observations)
was approximately 12–24 h. Given the muscle speciﬁcity of
MyoDiCre-dependent lineage marking (Kanisicak et al., 2009;
Yamamoto et al., 2009), MyoD–GFPþ cells observed at E11.5 and
E12.5 (Fig. S1) likely represent cells that had expressedMyoD at an
earlier stage, but not at the time of analysis, consistent with the
dynamic nature of MyoD expression.
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Fig. 2. Efﬁcient translational inhibition/ablation of the MyoD lineage by MyoDiCre-directed expression of DTA. (A, C, E, G) MyoDiCre-dependent lacZ expression driven by the
lacZ reporter, R26NZG, was ﬁrst detected in the myotomes at E10.5 (A), particularly in the hypaxial domains of interlimb somites (arrows), and in progenitors of head
musculature (arrowhead). LacZ expression subsequently marked all myogenic areas of the head, trunk and limb buds (C, E, G). (B, D, F, H) LacZ expressionwas undetectable in
embryos carrying the R26DTA allele. Slight non-speciﬁc “bluing” of larger embryos is common (H). (I–N) MyoD protein expression was lost by E12.5 in MyoDiCre/þ; R26DTA/þ
embryos. At E10.5 (I, J), modest effects of DTA expression were observed in hypaxial myotomes (brackets) and forelimb buds (LB). By E11.5 (K, L), the number of MyoDþ cells
and apparent expression levels per cell was greatly reduced. Examples of MyoDþ muscle beds in the control (K), and areas of persistent MyoD expression in a MyoDiCre/þ;
R26DTA/þ embryo, (L) are shown at the arrows. By E12.5 (M, N), MyoDþ cells were essentially undetectable (N). Panels K–N are assembled composites of multiple images.
Dotted lines were added to show embryo borders. Scale bars represent 200 μm.
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The above analysis shows that the combined use of both
lineage marking and immunoﬂuorescence provides a more accu-
rate measure of the size of the MyoD-expressing population than
either technique alone. Therefore, we assessed the overlap in Myf-
5þ and MyoDþ myoblast populations in MyoDiCre/þ;R26NG/þ
embryos using immunoﬂuorescence for Myf-5, and both lineage
marking and immunoﬂuorescence for MyoD. Use of the lineage
marker increased the apparent representation of MyoDþ cells at
both E11.5 and E12.5. This was most obvious in the myotomes
(Fig. 1B–G, M–Q), and probably reﬂects the earlier activation of
MyoD (and therefore the greater contribution of detectable lineage
marked cells) relative to the limb buds. Nevertheless, substantial
heterogeneity in MyoD and Myf-5 expression was evident in the
forelimb buds at E11.5 and in the myotomes at both E11.5 and
E12.5 (Fig. 1). The predominance of MyoDþMyf-5– cells in the
myotomes at E12.5 probably reﬂects the down-regulation of Myf-5
expression between E11.5 and E12.5 (Fig. 1C, M), although this
analysis cannot rule out the existence of a distinct, Myf-5-non-
expressing population. A small number of scattered cells that
expressed Myf-5 but not MyoD persisted in the myotomes through
E12.5 (Fig. 1P, Q), raising the possibility that a small MyoD-non-
expressing population exists. By E12.5, the great majority of
myogenic cells of the forelimb buds expressed both proteins
(Fig. 1R–V; data not shown).
Efﬁcient DTA-mediated ablation of MyoD-expressing myogenic
populations
Cre-dependent DTA ablation strategies were used to test for the
existence of a MyoD-negative myoblast population, and to deter-
mine if such a population could rescue myogenesis following
ablation of MyoD-expressing progenitors. To ablate MyoD-
expressing cells, embryos were produced that carry both the
MyoDiCre allele and the Rosa26eGFP-DTA allele (Ivanova et al., 2005;
hereafter referred to as R26DTA), allowing for the muscle-speciﬁc
expression of DTA upon iCre-mediated excision of the ﬂoxed stop
cassette containing eGFP. To best ensure efﬁcient cell ablation, we
used wild-type DTA for most experiments, although an attenuated
form of DTA (Wu et al., 2006; Haldar et al., 2008) was used in some
cases, where noted, to compare with Myf-5 lineage ablation
studies (Haldar et al., 2008).
We ﬁrst evaluated the effectiveness of DTA-mediated ablation
by conducting a developmental time course of MyoDiCre-depen-
dent lacZ expression (R26NZG allele; Yamamoto et al., 2009) in mice
that carry the DTA allele (MyoDiCre/þ;R26DTA/NZG). At E11.5 through
E13.5, control embryos lacking DTA showed robust, muscle-
speciﬁc β-gal staining (Fig. 2C, E, G) that was essentially identical
to the endogenous pattern of MyoD expression (Tajbakhsh et al.,
1997; Chen et al., 2002; Chen and Goldhamer, 2004; Kanisicak
et al., 2009; Yamamoto et al., 2009). E10.5 embryos (Fig. 2A)
showed weak β-gal expression, reﬂecting the aforementioned
delay in detectable reporter gene activity relative to endogenous
MyoD expression. MyoDiCre/þ embryos carrying Rosa26DTA/NZG, in
contrast, showed no β-gal activity at comparable stages (Fig. 2B, D,
F, H), indicating efﬁcient recombination of the Rosa26DTA locus
among MyoD-expressing progenitors of trunk, limb and head
musculature. Because both DTA and reporter gene expression
were dependent on Cre, these observations do not prove that all
myogenic cells that expressed endogenousMyoDwere targeted for
ablation. To address this point, expression of endogenous MyoD
protein was assessed in MyoDiCre/þ;R26DTA/þ embryos. At E10.5,
prior to signiﬁcant Cre-dependent reporter gene expression
(Fig. 2A), the number of MyoDþ cells was only modestly reduced
in MyoDiCre/þ;R26DTA/þ embryos relative to control embryos
(Fig. 2I, J), particularly in the hypaxial myotomal domains of trunk
somites, which represents the region where Cre-dependent
reporter gene activity is ﬁrst detected (Fig. 2A). By E11.5, however,
the number of MyoDþ cells and apparent MyoD protein abun-
dance per cell were greatly attenuated (Fig. 2K, L), and by E12.5,
MyoDþ cells were rarely observed (Fig. 2M, N). The loss of MyoD
immunoreactivity in DTA embryos occurred prior to, or concomi-
tant with, the stage at which MyoDiCre-dependent reporter gene
expression was initially detected in control embryos (Fig. 2A, C, J, L;
Kanisicak et al., 2009; Yamamoto et al., 2009), implying rapid
translational inhibition in DTA-expressing cells and rapid turnover
of MyoD protein, which has been documented in cultured myo-
blasts (Thayer et al., 1989; Carnac et al., 1998).
Since DTA is a translational inhibitor, an absence of MyoD
immunoreactivity or reporter gene expression does not necessa-
rily reﬂect the timing of cell ablation. To assess whether MyoD-
expressing cells persisted after the loss of MyoD immunoreactivity,
and to further document the efﬁciency of targeting DTA expression
to MyoD-expressing cells, we performed whole mount in situ
hybridization on DTA and control embryos between E11.5 and
E13.5. In contrast to the immunoﬂuorescence data, MyoD tran-
script levels in E11.5 MyoDiCre/þ;R26DTA/þ embryos were compar-
able to controls, except for a small reduction in the forelimb buds
(Fig. 3A, D), indicating the persistence of MyoD-expressing cells at
a stage when DTA-mediated inhibition of MyoD translation was
nearly complete. By E12.5, however, MyoD transcripts were
dramatically reduced, being restricted primarily to the dorsal-
and ventral-most interlimb body wall muscles, the hindlimb buds,
and the myotomes of the tail, the developmentally youngest
myotomes of the embryo (Fig. 3B, E) in which activation of DTA
expression would have been delayed relative to other myogenic
areas. By E13.5, MyoD transcripts were only detected in the most
posterior somites in the tail and the hindlimbs, where the signal
was barely detectable (Fig. 3C, F). Collectively, these data demon-
strate that the MyoDiCre allele effectively targets essentially all
MyoD-expressing cells for DTA-dependent translational inhibition,
and ultimately, ablation (see below).
DTA-mediated ablation of MyoDþ progenitors abolishes myogenesis
Muscle differentiation was assessed in MyoDiCre/þ;R26DTA/þ
embryos by immunoﬂuorescence for the differentiation markers,
Myogenin (Fig. S2) and MyHC (Fig. 4). A deﬁciency in hypaxial
myotomal differentiation was already evident at E10.5 in forelimb-
level and interlimb somites (Fig. 4A, B), the initial sites of MyoDiCre
expression in the body (see Fig. 2A). Early epaxial myotomal
myogenesis is dependent on Myf-5 (Braun et al., 1992; Kablar
et al., 1997; Tajbakhsh et al., 1997) and Mrf4 (Kassar-Duchossoy
et al., 2004), prior to the initiation of MyoD expression and,
accordingly, was not appreciably affected at this stage. In control
embryos at E11.5, MyHC staining in the body was primarily
observed in myotome-derived muscles and the shoulder region
(Fig. 4C). E11.5 represents the earliest stage of detectable muscle
differentiation in the forelimbs, and MyHC staining among control
embryos varied from barely detectable (data not shown) to the
level shown in Fig. 4C. This variation likely reﬂects small differ-
ences in developmental stage among embryos classiﬁed as E11.5.
In MyoDiCre/þ;R26DTA/þ embryos, MyHC staining in developing
skeletal muscles of the head, trunk and limbs was essentially
absent, except for rare cells weakly positive for MyHC in the
central myotome (Fig. 4D; data not shown). As expected, cardiac
muscle was unaffected in these embryos and stained intensively
with mAb MF20, which recognizes all forms of sarcomeric MyHC
(Bader et al., 1982). Differentiating skeletal muscle was undetect-
able in MyoDiCre/þR26DTA/þ embryos at E12.5, except for rare
individual cells in the limb or trunk (Fig. 4F, data not shown). This
is in striking contrast to control embryos, in which MyHC expres-
sion is pronounced in all muscle forming areas of the trunk and
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limbs (Fig. 4E). We also assessed muscle differentiation at E16.5 as
a sensitive endpoint assay for the presence and expansion of
myogenic progenitor cells, which could represent either a small,
persistent, MyoDlow population that expressed insufﬁcient Cre to
recombine the DTA allele, or a distinct population of MyoD-
negative cells. As assessed by MyHC expression and histological
observations (unpublished observations), differentiating skeletal
muscle was undetectable at E16.5 (Fig. 4G, H), indicating either the
complete loss of myogenic progenitor populations or their inabil-
ity to rescue myogenesis. Qualitatively similar results were
obtained using an attenuated form of DTA (R-DTA; Wu et al.,
2006; Haldar et al., 2008), although the time-course of cell
ablation was delayed and a few scattered MyHCþ cells persisted
at E16.5 (Fig. S3).
Myf-5þ myogenic progenitors are lost in MyoD lineage ablated
embryos
Immunoﬂuorescence and whole mount in situ hybridization
were used to determine whether Myf-5þ myogenic progenitors
persist in MyoDiCre/þR26DTA/þ embryos. Myf-5 immunoreactivity
was lost over a time course similar to that of MyoD (Fig. 2) and
MyHC (Fig. 4). E10.5 embryos showed a modest reduction in Myf-5
staining in hypaxial myotomes and some embryos also showed a
reduction in staining of the forelimb buds (Fig. 5A, B), although the
latter was a less consistent ﬁnding and the degree of reduction
was variable. The loss of Myf-5 immunoreactivity was pronounced
by E11.5 (Fig. 5C, D) and essentially complete by E12.5 (Fig. 5E, F).
Analysis of later stage embryos did not reveal an emergence and
expansion of Myf5þ progenitors, in contradistinction to Myf-5
lineage ablated embryos, in which compensatory expansion of
MyoDþ progenitors was observed (Gensch et al., 2008; Haldar
et al., 2008). The loss of Myf-5 mRNA closely paralleled the loss of
MyoD transcripts described above (Fig. 6). A modest reduction in
Myf-5 mRNA was observed in the forelimb buds at E11.5 (Fig. 6A,
D), followed by a sharp decline throughout the body by E12.5, and
loss of detectable Myf-5 transcripts by E13.5, except in the
developmentally youngest myotomes at the tip of the tail
(Fig. 6C, F). Collectively, the data presented thus far argue against
the existence of a distinct, MyoD-negative population of myogenic
progenitors.
Persistence of myogenic progenitors following ablation
of differentiating muscle
We next addressed whether cell non-autonomous effects could
account for the apparent absence of MyoD-negative progenitors.
For example, DTA-mediated disruption of the normal structural
and signaling environment caused by the loss of MyoDþ progeni-
tors and differentiating muscles might indirectly lead to the death
or fate change of MyoD-independent progenitors. We sought to
test this possibility by approximating these disruptive changes in
the developing muscle beds by speciﬁcally directing DTA expres-
sion to differentiating muscles without directly affecting muscle
progenitors. For these experiments, we used ACTA1Cre mice, in
which the α-skeletal actin promoter drives Cre expression (Miniou
et al., 1999), and evaluated the efﬁciency of ablation of differen-
tiating muscle, and the presence of muscle progenitors. α-skeletal
actin expression is initiated within 12 h of MyoD in hypaxial
muscles (approximately E10.5 and E11 in the forelimb buds for
MyoD and α-skeletal actin, respectively; Sassoon et al., 1988;
Tajbakhsh et al., 1997; Chen and Goldhamer, 2004), and the Cre-
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Fig. 3. Whole mount in situ hybridization for MyoD transcripts in control and MyoDiCre/þ;R26DTA/þ embryos. (A, D) E11.5 control and DTA embryos showed a similar pattern
and apparent abundance of MyoD transcripts, except for a modest reduction in the limb buds of DTA embryos. Staining in the head and dorsal neck in A is background
staining (asterisks). (B, E) By E12.5, MyoD transcripts in DTA embryos were dramatically reduced in developing muscle-forming regions of the head, trunk and limbs, with
strong staining primarily restricted to the dorsal- and ventral-most interlimb body wall muscles (white arrows), the hindlimbs (orange arrow), and the myotomes of the tail
(arrowhead). Similar areas are marked in control and DTA embryos. (C, F) By E13.5, staining for MyoD transcripts was undetectable except for faint staining in the hindlimbs
(orange arrows) and in the most posterior tail somites (arrowheads).
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dependent GFP reporter, R26NG (Yamamoto et al., 2009), is
expressed in the expected muscle speciﬁc pattern in ACTA1Cre
embryos at E11.5 and E12.5 (Fig. S4). In ACTA1Cre;R26DTA/þ
embryos, MyHC was undetectable at E11.5 and E12.5 (Fig. 7A, B,
E, F), and remained undetectable through E16.5 (data not shown),
demonstrating that differentiating muscle was efﬁciently targeted
for DTA expression. MyoD-expressing progenitors persisted
through E12.5 in ACTA1Cre;R26DTA/þ embryos, and only a minor
reduction in the number of MyoDþ cells was observed (Fig. S5).
In contrast to MyoD lineage-ablated embryos, targeting of differ-
entiating muscle for ablation had little effect on Myf-5 expression
at E11.5 (Fig. 7C, D). Myf-5þ cells were also abundant at E12.5,
although their number was reduced relative to control embryos
(Fig. 7G, H). Co-expression of Myf-5 in differentiating, DTA-
expressing, cells likely contributed to the loss of Myf-5
immunoreactivity, as overlap in Myf-5 and MyHC staining was
observed in control embryos at E12.5 (Fig. S6). We observed,
however, a substantial reduction in the apparent level of Myf-5
expression (Fig. 7G, H), which may indicate that the maintenance
of Myf-5 expression is dependent on the muscle environment, as
has been shown for Pax7 (Kassar-Duchossoy et al., 2005). The
persistence of Myf-5þ progenitors in ACTA1Cre;R26DTA/þ embryos
during the time frame in which essentially all Myf-5þ progenitors
are lost in MyoDiCre/þR26DTA/þ embryos indicates that cell non-
autonomous effects cannot explain the rapid loss of Myf-5þ cells
in MyoD lineage-ablated embryos. This is consistent with the
capacity of myoblasts to survive, proliferate and undergo myogenic
differentiation in the setting of widespread DTA-mediated disrup-
tion of the muscle beds by ablation of Myf-5þ progenitors
(Gensch et al., 2008; Haldar et al., 2008).
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Fig. 4. Loss of MyHC expression in MyoD lineage-ablated embryos. (A, B) Loss of MyHC immunoreactivity was ﬁrst observed in hypaxial myotomes at forelimb and inter-
limb levels at E10.5 (bracket). (C, D) MyHC immunoreactivity in E11.5 MyoDiCre/þ;R26DTA/þ embryos was restricted to a few scattered cells in the trunk (D; small yellow box).
This area is enlarged in the inset to show MyHCþ cells. Examples of MyHCþ muscle masses in the trunk and forelimb of a control embryo (C) are shown at the arrows.
MyHC staining in the forelimb buds of this control embryo (C) was greater than typical for this stage. The heart stained intensively with mAb MF20 (arrowhead), which
recognizes all forms of sarcomeric myosin. (E, F) By E12.5, MyHC staining of skeletal muscle was abolished. MyHC expression in the heart (arrowheads) serves as a positive
internal control for staining. (G, H) Differentiated skeletal muscle was absent in E16.5 DTA embryos, demonstrating the lack of functional MyoD lineage-independent
compensatory pathways for muscle differentiation in MyoDiCre/þ;R26DTA/þ embryos. MyHC staining in DTA embryos was restricted to the heart and certain larger vessels of
the circulatory system (examples at arrowheads). Dark areas in H are ﬂuid ﬁlled spaces devoid of tissue (asterisks), which is common in late stage embryos lacking skeletal
muscle. Panels G and H were counterstained with DAPI. Panels C, D, G, and H are assembled composites of multiple images. Scale bars represent 200 μm in A–F, and 400 μm
in G and H.
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Pax7þ satellite cell progenitors are lost in MyoD lineage ablated
embryos
Satellite cells are the major stem cell responsible for muscle
regeneration (Zammit, 2008; Lepper et al., 2011; Murphy et al.,
2011; McCarthy et al., 2011). We previously showed that satellite
cells are derived from MyoD-expressing progenitors, although
MyoD function is not required in these progenitors for satellite
cell development (Kanisicak et al., 2009). To address whether
other embryonic cell populations can serve as satellite cell
progenitors when MyoDþ cells are ablated, we assessed Pax7
expression in MyoD lineage-ablated embryos. Markers exclusive to
satellite cell progenitors are not available, and Pax7 marks pro-
genitors of both satellite cells and myogenic cells engaged in
ongoing myogenesis (Relaix et al., 2004, 2005; Kassar-Duchossoy
et al., 2005; Hutcheson et al., 2009; Lepper and Fan, 2010). In the
limb buds, where most investigations have focused, Pax7 is ﬁrst
activated at approximately E11.5 in a subset of Pax3þ progenitors
(Relaix et al., 2004, 2005; Kassar-Duchossoy et al., 2005;
Hutcheson et al., 2009), which are MRF-negative as they migrate
from the hypaxial dermomyotome of limb-level somites and enter
the developing limbs by E10.5 (Bober et al., 1994; Relaix et al.,
2004). As expected, Pax3þ cells were abundant in the premuscle
masses of E10.5 forelimb buds (Fig. 8A). We also noted the
presence of a few scattered Pax7þ cells at this stage (Fig. 8C).
No consistent reduction in Pax3 or Pax7 staining was observed in
forelimb buds of MyoDiCre/þ;R26DTA/þ embryos at E10.5 (Fig. 8A–
D), which is prior to detectable MyoDiCre/þ-dependent gene
expression (Fig. 2A; Kanisicak et al., 2009). By E12.5, however,
when the major muscle groups of the limbs and trunk are marked
by robust Pax7 expression in control embryos (Fig. 8E), Pax7
staining in MyoD lineage-ablated embryos was restricted to a
small number of individual or clustered cells, (Fig. 8F), consistent
with the view that the great majority of Pax7þ progenitors
express MyoD by E12.5. Pax7þ progenitors were not observed in
MyoDiCre/þ;R26DTA/þ embryos at E16.5 (Fig. 8I, J), the approximate
stage at which satellite cells can be anatomically identiﬁed as
Pax7þ cells lying beneath the nascent muscle ﬁber basal lamina
(Kassar-Duchossoy et al., 2005; Relaix et al., 2005; Lepper and Fan,
2010). Importantly, Pax7þ cells were abundant in the muscle
forming areas of the limbs and trunk of E12.5 ACTA1Cre;R26DTA/þ
embryos (Fig. 8G, H), and Pax7þ progenitors persisted through
E16.5 (Fig. 8K–N), despite the absence of differentiating skeletal
muscle. We note, however, that the number of Pax7þ cells was
substantially reduced at both stages relative controls, which might
reﬂect a need for paracrine signaling by differentiating skeletal
muscle to maintain Pax7 expression (Kassar-Duchossoy et al.,
2005). Collectively, these data show that cell-non-autonomous
effects cannot explain the rapid and complete loss of Pax7
immunoreactivity in MyoD lineage-ablated embryos, although
the absence of differentiating muscle probably contributed to the
reduction in Pax7 immunoreactivity.
Discussion
Deﬁning the sizes and interrelationship of MRF-expressing
myogenic populations is essential for a complete understanding
of the regulatory circuitry controlling myogenic lineage determi-
nation and the compensatory mechanisms that render each factor
individually dispensable for skeletal muscle development. In this
study, we used DTA-mediated cell ablation, together with immu-
noﬂuorescence analyses and lineage tracing, to investigate the
interrelationship of MyoDþ and Myf-5þ myogenic populations,
and to speciﬁcally test whether MyoDþ progenitors are essential
for muscle development. In stark contrast to the phenotype of
Myf-5 lineage-ablated embryos, in which myogenesis is delayed
but shows a full recovery by fetal stages (Gensch et al., 2008;
Haldar et al., 2008), loss of MyoD-expressing progenitors resulted
in the cessation of myogenesis, as demonstrated by the complete
loss of differentiating muscle subsequent to MyoDiCre-dependent
activation of DTA expression. Importantly, Myf-5þ progenitors
were lost concomitant with the loss of MyoDþ progenitors,
suggesting that all Myf-5þ myogenic cells express MyoD. This
conclusion is supported by our analysis of Myf-5 protein expres-
sion in E12.5 MyoDiCre/þ;R26NG/þ embryos, in which only rare
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Fig. 5. Loss/translational inhibition of Myf-5þ progenitors in MyoD lineage-ablated
embryos. (A, B) As with MyoD protein expression, partial loss of Myf-5 immunor-
eactivity was ﬁrst observed at E10.5 in the forelimb buds and in hypaxial myotomes at
limb (bracket) and inter-limb levels at E10.5. (C, D) By E11.5, Myf-5 immunoreactivity
inMyoDiCre/þ;R26DTA/þ embryos (D) was restricted to a few scattered cells in the trunk
and limb buds (arrows). Examples of Myf-5þ muscle masses in the trunk and
forelimb bud of a control embryo (C) are shown at the arrows. (E, F) By E12.5, Myf-5
staining of skeletal muscle in MyoD lineage-ablated embryos (F) was essentially
abolished. Examples of Myf-5þ muscle masses in the trunk and forelimb of a control
embryo (E) are shown at the arrows. E11.5 and E12.5 panels are assembled composites
of multiple images. Scale bars represent 200 μm.
W.M. Wood et al. / Developmental Biology 384 (2013) 114–127122
E11.5
M
yo
D
iC
re
/+
;R
26
D
TA
/+
C
on
tr
ol
E12.5 E13.5
Fig. 6. Whole mount in situ hybridization for Myf-5 transcripts in control and MyoD lineage-ablated embryos. (A, D) At E11.5, clear effects of DTA expression were restricted
to the forelimb buds (arrows). Staining in the head and dorsal neck in (A) and (D) is background staining (asterisks). (B, E) By E12.5, Myf-5 transcripts inMyoDiCre/þ;R26DTA/þ
embryos were markedly reduced in muscle-forming regions of the head, trunk and limbs, with staining primarily restricted to the dorsal- and ventral-most interlimb body
wall muscles (white arrows), the hindlimbs (orange arrows), and the myotomes of the tail (arrowheads). Similar areas are marked in control and MyoDiCre/þ;R26DTA/þ
embryos. (C, F) By E13.5, staining for Myf-5 transcripts was undetectable except for very faint staining in the hindlimbs (orange arrows), and in the most posterior tail
somites (arrowheads).
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Fig. 7. Persistence of Myf-5þ progenitors when differentiating skeletal muscle was targeted for DTA-mediated ablation. (A, B, E, F) Except for rare cells (arrow, F), MyHC
staining is completely lost at E11.5 and E12.5 in ACTA1Cre;R26DTA/þ embryos. Arrow in A, MyHCþ myotome. Arrows in E, examples of MyHCþ muscle groups in the trunk
and limb. The heart is robustly MyHCþ in both control and experimental embryos (arrowheads in A, B, E, and F). (C, D) Myf-5 staining in the myotomes of limb-level (white
arrows) and interlimb somites is reduced in ACTA1Cre;R26DTA/þ embryos at E11.5, whereas staining of the dorsal and ventral premuscle masses (orange arrows) of the
forelimb buds is not appreciably affected. (G H) At E12.5, the majority of Myf-5þ progenitors persisted, although the immunoﬂuorescence signal is reduced relative to
controls. Panels E and F were counterstained with DAPI. Panels B, C, D, G, and H are assembled composites of multiple images. Scale bars represent 200 μm.
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Myf-5þ cells were observed that were not lineage-marked for
MyoD expression or did not express detectable MyoD protein.
As embryos lacking both MyoD and Myf-5 undergo limited and
transient embryonic myogenesis, which is directed by the related
factor, Mrf4 (Kassar-Duchossoy et al., 2004), we attempted to
evaluate the possible presence of a signiﬁcant pool of
Mrf4þMyoD– progenitors. These experiments, however, were
inconclusive because of the poor quality of immunoﬂuorescence
staining with commercially available antibodies against Mrf4 (data
not shown). However, 498% of Pax7þ progenitors in the hin-
dlimbs at E13.5 were lineage marked by the historical or ongoing
expression of MyoD (unpublished observations), arguing against
the existence of a distinct Mrf4þMyoD– progenitor population.
Clearly, if a very small Mrf4þMyoD– population exists, it is
incapable of supporting a detectable level of myogenesis in MyoD
lineage-ablated embryos subsequent to the initial formation of the
myotome, which is under the genetic control ofMyf-5 (Braun et al.,
1992; Tajbakhsh et al., 1997) and Mrf4 (Kassar-Duchossoy et al.,
2004), prior to the induction of MyoD.
The present study was not designed to distinguish whether
Myf-5 is co-expressed with MyoD in all myogenic cells, or whether
Myf-5þ cells represent a subset of the MyoDþ progenitor pool.
Results of Cre/loxP-dependent DTA lineage ablation using Myf-5Cre
alleles support the existence of a functionally signiﬁcant pool of
Myf-5–MyoDþ progenitors (Gensch et al., 2008; Haldar et al.,
2008). However, the efﬁciency of Cre-mediated recombination is
G H
I J
E F
LB LB
LB
LB
LB LB
B
K
M N
L
B
A C
LBLB
Pax7
Control MyoDiCre/+;R26DTA/+ Control MyoDiCre/+;R26DTA/+
E1
0.
5
E1
2.
5
E1
6.
5
Pax3 Pax7
Control MyoDiCre/+;R26DTA/+ Control ACTA1Cre/+;R26DTA/+
B D
Fig. 8. Loss/translational inhibition of Pax7þ progenitors in MyoD lineage-ablated embryos. (A–D) Expression of Pax3 and Pax7 were not appreciably affected inMyoDiCre/þ;
R26DTA/þ embryos at E10.5. Weak Pax7 staining (brackets) in the proximal forelimb buds is ﬁrst detected at this stage. (E, F) Very few Pax7þ cells are detectable at E12.5 in
MyoD lineage-ablated embryos. A small cluster of Pax7þ cells in the trunk of this MyoDiCre/þ;R26DTA/þ embryo (F) is shown at the arrow. Pax7 staining of the neural tube
(arrowheads) serves as a positive internal control for staining. Pax7 is robustly expressed in muscle groups of the trunk and limbs in control embryos (E). (G, H) Many Pax7þ
cells persisted at E12.5 in ACTA1Cre; R26DTA/þ embryos (H), although their number was reduced relative to controls (G). Arrowheads, Pax7 staining of the neural tube. (I, J)
Longitudinal sections through the forelimbs of control (I) and MyoDiCre/þ;R26DTA/þ (J) embryos at E16.5. Pax7þ cells were abundant in the muscle beds of control forelimbs
(arrows), but were absent in MyoD lineage-ablated forelimbs, which lack differentiating skeletal muscle (see Fig. 4H). Yellow arrowheads, autoﬂuorescence associated with
the periosteum of the developing bone (B). (K, L) Transverse sections through the ventral body wall of control (K) and ACTA1Cre; R26DTA/þ (L) E16.5 embryos. Pax7þ
progenitors were readily apparent, but reduced in number, in ACTA1Cre; R26DTA/þ embryos. Numbers of Pax7þ cells varied considerably between sections and this is an
“average” example. (M, N) Longitudinal sections through the distal hindlimbs of control and ACTA1Cre;R26DTA/þ embryos at E16.5. Pax7þ cells were abundant in the muscle
beds of control embryos (M). Many Pax7þ progenitors persisted in the limbs of ACTA1Cre;R26DTA/þ embryos (N) despite the absence of differentiating skeletal muscle,
although their numbers were consistently reduced relative to controls. Panels I and J were counterstained with DAPI. Panels E–H are assembled composites of multiple
images. LB, limb bud. Scale bars represent 200 μm in A–F and I–J, 400 μm in G and H, 100 μm in K–N.
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highly dependent on both the Cre driver and the ﬂoxed
target allele (Nagy, 2000; Lewandoski, 2001; Ma et al., 2008;
Sambasivan et al., 2013), and it is difﬁcult to exclude the possibility
that the apparent presence of Myf-5-negative cells was due to
incomplete Cre recombination among Myf-5-expressing progeni-
tors (also see Sambasivan et al., 2013). Whereas the loss of Cre-
dependent reporter gene expression in DTA embryos was clearly
shown (Gensch et al., 2008; Haldar et al., 2008), these data did not
rule out the existence of Myf-5þ cells in which both the ﬂoxed
reporter and DTA alleles remained unrecombined because of
insufﬁcient levels of Cre. Given these considerations, the possible
existence of a distinct population of Myf-5-negative myogenic
progenitors requires further investigation. Nevertheless, the recov-
ery of myogenesis following ablation of most Myf-5-expressing
progenitors (Gensch et al., 2008; Haldar et al., 2008) dramatically
demonstrates the marked compensatory capacity of developing
skeletal muscle. Determining whether rescue of myogenesis in
these embryos is driven by expansion of MRFþ myoblasts, more
primitive, PaxþMRF– progenitors, or both, will provide important
insights into cellular mechanisms that drive this regulative
capacity.
While we interpret the loss of Myf-5 expression in MyoDiCre/þ;
R26DTA/þ embryos as evidence for co-expression of MyoD in the
great majority of Myf-5-expressing progenitors cells outside of the
early myotome, it is important to consider other possible explana-
tions. For example, we cannot exclude a priori the existence of a
small, distinct Myf-5þMyoD– progenitor population that was lost
only after fusion to MyoDþ , dying myoblasts. Notwithstanding the
unlikelihood that DTA-expressing myoblasts remain fusion com-
petent, this scenario is inconsistent with the fact that Myf-5
immunoreactivity is almost completely lost by E11.5, a stage at
which the developing muscle beds are comprised predominantly
of mononuclear progenitors. Further, any minor role that fusion
might play in the loss of progenitor cells did not prevent rescue of
myogenesis by MyoDþ progenitors following ablation of Myf-5-
expressing cells (Gensch et al., 2008; Haldar et al., 2008).
We also used ACTA1Cre mice (Miniou et al., 1999) to test
whether cell non-autonomous effects could explain the loss of
Myf-5þ progenitors by assessing the consequences on progenitor
populations when DTA expression was directed speciﬁcally to
differentiating skeletal muscles. Strikingly, while Myf-5 expression
was essentially absent by E12.5 in MyoD lineage-ablated embryos,
large numbers of Myf-5þ progenitors persisted through E12.5 in
ACTA1Cre;R26DTA/þ embryos. These data strongly suggest that the
rapid loss of Myf-5þ myogenic progenitors in MyoDiCre/þ;R26DTA/þ
embryos was largely due to DTA expression in those progenitors,
and cannot be explained by cell non-autonomous effects. The ability
of MyoDþ cells to rescue myogenesis in Myf-5 lineage-ablated
embryos (Gensch et al., 2008; Haldar et al., 2008) also shows that
widespread disruption of the muscle environment is compatible
with myogenic progenitor cell survival, expansion and differentia-
tion. Nevertheless, we did observe a reduction in Myf-5þ progeni-
tor numbers and expression levels in ACTA1Cre;R26DTA/þ muscle
beds relative to control embryos, consistent with some contribution
of the muscle environment on progenitor cell loss or Myf-5
expression (see below). We showed, however, that much of the
loss of Myf-5 immunoreactivity in ACTA1Cre;R26DTA/þ embryos at
E12.5 can be accounted for by the loss (or translational inhibition
within) of nascent myocytes and muscle ﬁbers in which Myf-5 is
normally expressed.
Pax7 is an accepted and widely utilized marker for satellite
cells and their progenitors (Seale et al., 2000; Kassar-Duchossoy
et al., 2005; Relaix et al., 2005; Bosnakovski et al., 2008) and is an
early marker of myogenic lineage restriction in the limbs
(Hutcheson et al., 2009; Lepper and Fan, 2010). We showed that
Pax7 expression is lost inMyoDiCre/þ;R26DTA/þ embryos, consistent
with previous lineage analyses, which demonstrated that satellite
cell progenitors express MyoD prior to birth (Kanisicak et al.,
2009). An unexpected ﬁnding of the current study, however, was
the rapid loss, by E12.5, of essentially all Pax7þ cells. While
existing markers do not allow the speciﬁc identiﬁcation of Pax7þ
satellite cell progenitors among the Pax7þ myogenic population,
conditional lineage labeling with a Pax7CreER driver (Pax7CE)
demonstrated the emergence of Pax7þ satellite cell progenitors
by E9.5 and E11.5 in certain trunk and limb muscles, respectively
(Lepper and Fan, 2010). As such, the loss of Pax7 immunoreactivity
in MyoD lineage-ablated embryos suggests that MyoD is activated
in at least some, and perhaps all, satellite cell progenitors by E12.5.
Accordingly, conditional lineage tracing revealed the emergence of
MyoDþ satellite cell progenitors by E12.5, although a relatively
low Cre recombination efﬁciency precluded precise quantiﬁcation
(unpublished observations). Importantly, however, immunohisto-
chemical studies have shown that cells expressing Pax3, Pax7 or
both markers, but negative for MRF expression (PaxþMRF–),
persist through fetal stages (Kassar-Duchossoy et al., 2005;
Relaix et al., 2005). Whereas the presence of progenitors with this
marker proﬁle may reﬂect, in part, the dynamic expression and
rapid turnover of MyoD and Myf-5 (Kitzmann et al., 1998; Thayer
et al., 1989; Carnac et al., 1998; Kanisicak et al., 2009), we cannot
exclude the possibility that MyoDþ satellite cell progenitors
continually emerge from a persistent PaxþMRF– pool. This
scenario can be reconciled with the present DTA ablation data if
MyoD expression is activated prior to or concomitant with Pax7 in
some Pax3þ progenitors, or if Pax7þ cells generated after E12.5
escaped detection because of the rapid, subsequent, activation of
MyoDiCre-dependent DTA expression. In fact, MyoD expression
precedes Pax7 expression in limb muscle progenitors (Tajbakhsh
et al., 1997; Chen and Goldhamer, 2004; Relaix et al., 2004;
unpublished observations), supporting the former mechanism.
Disruption of the muscle environment also probably contributed
to the loss of Pax7 immunoreactivity, since Pax7 staining was
reduced when differentiating cells, which do not express Pax7
(Kassar-Duchossoy et al., 2005; Relaix et al., 2005; Olguin et al.,
2007; Dey et al., 2011), were targeted for ablation. While Pax7þ
cells are resistant to apoptosis in muscle-deﬁcient embryos,
paracrine signaling by differentiating muscle may regulate the
maintenance of Pax7 expression (Kassar-Duchossoy et al., 2005).
Nevertheless, the dramatic difference in the timing and extent of
loss of Pax7 immunoreactivity in MyoDiCre/þ;R26DTA/þ and
ACTA1Cre;R26DTA/þ embryos is consistent with the notion that
most Pax7þ progenitors express MyoD, at least transiently,
by E12.5.
Satellite cell progenitors of the limb share a number of funda-
mental properties with fetal myoblasts or their progenitors,
including their origin from the dermomyotome of limb-level
somites (Armand et al., 1983; Gros et al., 2005; Schienda et al.,
2006; Lepper and Fan, 2010), sequential activation of Pax3 and
Pax7 expression (Bober et al., 1994; Relaix et al., 2004; Hutcheson
et al., 2009) and expression of MyoD (Kanisicak et al., 2009;
present study), Myf-5 (Biressi et al., 2013) and Mrf4 (Sambasivan
et al., 2013). Indeed, no molecular properties unique to satellite
cell progenitors have been identiﬁed, and it remains unclear
whether satellite cell progenitors represent a distinct, MyoD-
expressing lineage, or how and when they are partitioned from
myogenic populations engaged in embryonic and fetal myogenesis.
In this regard, recent data have demonstrated microRNA-mediated
translational inhibition of Myf-5 mRNA in adult quiescent satellite
cells, a regulatory mechanism that may prevent premature activa-
tion of the myogenic program (Crist et al., 2012). Importantly, Cre-
based lineage analyses and DTA ablation rely on transcriptional
output from a locus of interest and do not address whether the
cognate protein is expressed. Whereas all Cre protein-positive cells
W.M. Wood et al. / Developmental Biology 384 (2013) 114–127 125
of the forelimb muscle beds of MyoDiCre mice were positive for
MyoD protein at E16.5 (Kanisicak et al., 2009), and the great
majority of MyoD lineage-labeled cells at E12.5 expressed MyoD
protein (present study), markers speciﬁc to satellite cell progenitors
are required to formally demonstrate expression of MyoD protein in
this population. If MyoD protein is expressed in satellite cell
progenitors during embryonic development, it will be important
to determine how these progenitors are prevented from engaging
in ongoing embryonic and fetal myogenesis, and whether expres-
sion of this key lineage-determining factor is sufﬁcient for stable
myogenic programming of satellite cells.
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